🇺🇸 FDA
Patent

US 11959096

Methods for selective inhibition of pluripotent stem cells

granted A61KA61K35/545A61P

Quick answer

US patent 11959096 (Methods for selective inhibition of pluripotent stem cells) held by The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer expires Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Government of the United States of America as Represented by the Secretary of the Department of Health and Human Services NIH, Office of Technology Transfer
Grant date
Tue Apr 16 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K35/545, A61P, A61P35/00, A61P41/00